Benchling was last valued at $6.1B. It dates from Nov 2021. The company is private, so there is no listed share price.
One company valuation: $6.1B, dated Nov 2021.
The last valuation is $6.1B.
Lead investors for each round are in the funding timeline.
The closest biotech/research software peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Benchling is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
